Crosslinked ionizable lipids reprogram dendritic cell metabolism for potent mRNA vaccination

Area of Science:

• Immunology
• Biochemistry
• Nanotechnology

Background:

• Metabolic reprogramming of immune cells can enhance immune responses.
• Lipid nanoparticles (LNPs) are crucial for mRNA vaccine delivery.
• Current LNPs may have limitations in targeting and immunogenicity.

Purpose of the Study:

• To develop a novel LNP with metabolic modulatory properties for mRNA vaccines.
• To investigate the mechanism of action of the new LNP.
• To evaluate the efficacy and safety of the LNP in vaccine models.

Main Methods:

• Design and synthesis of a crosslinked ionizable lipid (C12-2aN) for LNPs.
• Assessment of mRNA expression and dendritic cell glycolysis.
• In vivo testing of LNPs in SARS-CoV-2 and cancer vaccine models.

Main Results:

• C12-2aN LNPs effectively delivered mRNA and stimulated glycolysis via mTORC2.
• LNPs demonstrated potent vaccine efficacy in SARS-CoV-2 and cancer models.
• C12-2aN LNPs showed reduced off-target delivery and lower immunogenicity compared to controls.

Conclusions:

• The developed C12-2aN LNP integrates mRNA delivery with metabolic reprogramming.
• This approach enhances vaccine efficacy and safety profiles.
• These findings present a significant advancement for next-generation mRNA LNP vaccines.